Selective pharmacologic inhibition of a PASTA kinase increases Listeria monocytogenes susceptibility to β-lactam antibiotics

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 8, 2014, Pages 4486-4494

  Pensinger, Daniel A ^a   Aliota, Matthew T ^a,b   Schaenzer, Adam J ^a,b   Boldon, Kyle M ^a,b   Ansari, Israr Ul H ^b   Vincent, William J B ^a   Knight, Benjamin ^a   Reniere, Michelle L ^d   Striker, Rob ^a,b,c   Sauer, John Demian ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c WILLIAM S MIDDLETON MEMORIAL VETERANS HOSPITAL   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZD5438; CEPHALOSPORIN DERIVATIVE; IMIDAZOLE DERIVATIVE; PENICILLIN BINDING PROTEIN; PENICILLIN DERIVATIVE; PROTEIN KINASE INHIBITOR; PROTEIN SERINE THREONINE KINASE; PYRIMIDINE DERIVATIVE; STAUROSPORINE; VANCOMYCIN;

ANTAGONISTS AND INHIBITORS; CELL WALL; DRUG EFFECTS; GENE DELETION; GENETICS; LISTERIA MONOCYTOGENES; METABOLISM; MULTIDRUG RESISTANCE; PHOSPHORYLATION;

ANTI-BACTERIAL AGENTS; CELL WALL; CEPHALOSPORINS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENE DELETION; IMIDAZOLES; LISTERIA MONOCYTOGENES; PENICILLIN-BINDING PROTEINS; PENICILLINS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PYRIMIDINES; STAUROSPORINE; VANCOMYCIN;

EID: 84905386008     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02396-14     Document Type: Article

References (42)

1. Freitag NE, Port GC, Miner MD. 2009. Listeria monocytogenes-from saprophyte to intracellular pathogen. Nat. Rev. Microbiol. 7:623-628. http://dx.doi.org/10.1038/nrmicro2171.
2. Lecuit M. 2007. Human listeriosis and animal models. Microbes Infect. 9:1216-1225. http://dx.doi.org/10.1016/j.micinf.2007.05.009.
3. Schlech WF, III, Lavigne PM, Bortolussi RA, Allen AC, Haldane EV, Wort AJ, Hightower AW, Johnson SE, King SH, Nicholls ES, Broome CV. 1983. Epidemic listeriosis-evidence for transmission by food. N. Engl. J. Med. 308:203-206. http://dx.doi.org/10.1056/NEJM198301273080407.
4. Drevets DA, Bronze MS. 2008. Listeria monocytogenes: epidemiology, human disease, and mechanisms of brain invasion. FEMS Immunol. Med. Microbiol. 53:151-165. http://dx.doi.org/10.1111/j.1574-695X.2008.00404.x.
5. Temple ME, Nahata MC. 2000. Treatment of listeriosis. Ann. Pharmacother. 34:656-661. http://dx.doi.org/10.1345/aph.19315.
6. McCollum JT, Cronquist AB, Silk BJ, Jackson KA, O'Connor KA, Cosgrove S, Gossack JP, Parachini SS, Jain NS, Ettestad P, Ibraheem M, Cantu V, Joshi M, Du Vernoy T, Fogg NW, Jr, Gorny JR, Mogen KM, Spires C, Teitell P, Joseph LA, Tarr CL, Imanishi M, Neil KP, Tauxe RV, Mahon BE. 2013. Multistate outbreak of listeriosis associated with cantaloupe. N. Engl. J. Med. 369:944-953. http://dx.doi.org/10.1056/NEJMoa1215837.
7. Jones EM, MacGowan AP. 1995. Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur. J. Clin. Microbiol. Infect. Dis. 14:165-175. http://dx.doi.org/10.1007/BF02310351.
8. Lewis K. 2013. Platforms for antibiotic discovery. Nat. Rev. Drug Discov. 12:371-387. http://dx.doi.org/10.1038/nrd3975.
9. Sader HS, Jones RN. 2009. Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008). Diagn. Microbiol. Infect. Dis. 65:158-162. http://dx.doi.org/10.1016/j.diagmicrobio.2009.06.016.
10. Villegas-Estrada A, Lee M, Hesek D, Vakulenko SB, Mobashery S. 2008. Co-opting the cell wall in fighting methicillin-resistant Staphylococcus aureus: potent inhibition of PBP 2a by two anti-MRSA beta-lactam antibiotics. J. Am. Chem. Soc. 130:9212-9213. http://dx.doi.org/10.1021/ja8029448.
11. Richter SS, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Kroeger JS, Biek D, Critchley IA, Diekema DJ, Doern GV. 2011. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009. Antimicrob. Agents Chemother. 55:4154-4160. http://dx.doi.org/10.1128/AAC.00315-11.
12. Yeats C, Finn RD, Bateman A. 2002. The PASTA domain: a beta-lactambinding domain. Trends Biochem. Sci. 27:438. http://dx.doi.org/10.1016/S0968-0004 (02) 02164-3.
13. Pereira SF, Goss L, Dworkin J. 2011. Eukaryote-like serine/threonine kinases and phosphatases in bacteria. Microbiol. Mol. Biol. Rev. 75:192-212. http://dx.doi.org/10.1128/MMBR.00042-10.
14. Fernandez P, Saint-Joanis B, Barilone N, Jackson M, Gicquel B, Cole ST, Alzari PM. 2006. The Ser/Thr protein kinase PknB is essential for sustaining mycobacterial growth. J. Bacteriol. 188:7778-7784. http://dx.doi.org/10.1128/JB. 00963-06.
15. Hussain H, Branny P, Allan E. 2006. A eukaryotic-type serine/threonine protein kinase is required for biofilm formation, genetic competence, and acid resistance in Streptococcus mutans. J. Bacteriol. 188:1628-1632. http://dx.doi.org/10.1128/JB.188.4.1628-1632.2006.
16. Lougheed KE, Osborne SA, Saxty B, Whalley D, Chapman T, Bouloc N, Chugh J, Nott TJ, Patel D, Spivey VL, Kettleborough CA, Bryans JS, Taylor DL, Smerdon SJ, Buxton RS. 2011. Effective inhibitors of the essential kinase PknB and their potential as anti-mycobacterial agents. Tuberculosis (Edinb.) 91:277-286. http://dx.doi.org/10.1016/j.tube.2011.03.005.
17. Seal A, Yogeeswari P, Sriram D, Consortium O, Wild DJ. 2013. Enhanced ranking of PknB inhibitors using data fusion methods. J. Cheminform. 5:2. http://dx.doi.org/10.1186/1758-2946-5-2.
18. Chapman TM, Bouloc N, Buxton RS, Chugh J, Lougheed KE, Osborne SA, Saxty B, Smerdon SJ, Taylor DL, Whalley D. 2012. Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. Bioorg. Med. Chem. Lett. 22:3349-3353. http://dx.doi.org/10.1016/j.bmcl.2012.02. 107.
19. Tamber S, Schwartzman J, Cheung AL. 2010. Role of PknB kinase in antibiotic resistance and virulence in community-acquired methicillinresistant Staphylococcus aureus strain USA300. Infect. Immun. 78:3637-3646. http://dx.doi.org/10.1128/IAI.00296-10.
20. Beltramini AM, Mukhopadhyay CD, Pancholi V. 2009. Modulation of cell wall structure and antimicrobial susceptibility by a Staphylococcus aureus eukaryote-like serine/threonine kinase and phosphatase. Infect. Immun. 77:1406-1416. http://dx.doi.org/10.1128/IAI.01499-08.
21. Kristich CJ, Wells CL, Dunny GM. 2007. A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc. Natl. Acad. Sci. U. S. A. 104:3508-3513. http://dx.doi.org/ 10.1073/pnas.0608742104.
22. Topp S, Reynoso CM, Seeliger JC, Goldlust IS, Desai SK, Murat D, Shen A, Puri AW, Komeili A, Bertozzi CR, Scott JR, Gallivan JP. 2010. Synthetic riboswitches that induce gene expression in diverse bacterial species. Appl. Environ. Microbiol. 76:7881-7884. http://dx.doi.org/10.1128/AEM.01537-10.
23. Horton RM, Cai ZL, Ho SN, Pease LR. 1990. Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8:528-535.
24. Lauer P, Chow MY, Loessner MJ, Portnoy DA, Calendar R. 2002. Construction, characterization, and use of two Listeria monocytogenes site-specific phage integration vectors. J. Bacteriol. 184:4177-4186. http://dx.doi.org/10.1128/JB.184.15.4177-4186.2002.
25. Camilli A, Tilney LG, Portnoy DA. 1993. Dual roles of plcA in Listeria monocytogenes pathogenesis. Mol. Microbiol. 8:143-157. http://dx.doi.org/10. 1111/j.1365-2958.1993.tb01211.x.
26. Phan-Thanh L, Gormon T. 1997. A chemically defined minimal medium for the optimal culture of Listeria. Int. J. Food Microbiol. 35:91-95. http://dx.doi.org/10.1016/S0168-1605 (96) 01205-6.
27. Glaser P, Frangeul L, Buchrieser C, Rusniok C, Amend A, Baquero F, Berche P, Bloecker H, Brandt P, Chakraborty T, Charbit A, Chetouani F, Couve E, De Daruvar A, Dehoux P, Domann E, Dominguez-Bernal G, Duchaud E, Durant L, Dussurget O, Entian KD, Fsihi H, Garcia-del Portillo F, Garrido P, Gautier L, Goebel W, Gomez-Lopez N, Hain T, Hauf J, Jackson D, Jones LM, Kaerst U, Kreft J, Kuhn M, Kunst F, Kurapkat G, Madueno E, Maitournam A, Vicente JM, Ng E, Nedjari H, Nordsiek G, Novella S, De Pablos B, Perez-Diaz JC, Purcell R, Remmel B, Rose M, Schlueter T, Simoes N, Tierrez A, Vazquez-Boland JA, Voss H, Wehland J, Cossart P. 2001. Comparative genomics of Listeria species. Science 294:849-852. http://dx.doi.org/10.1126/science.1063447.
28. Karaman MW, Herrgard S, Treiber DK, Gallant P, Atteridge CE, Campbell BT, Chan KW, Ciceri P, Davis MI, Edeen PT, Faraoni R, Floyd M, Hunt JP, Lockhart DJ, Milanov ZV, Morrison MJ, Pallares G, Patel HK, Pritchard S, Wodicka LM, Zarrinkar PP. 2008. A quantitative analysis of kinase inhibitor selectivity. Nat. Biotechnol. 26:127-132. http://dx.doi.org/10.1038/nbt1358.
29. Byth KF, Thomas A, Hughes G, Forder C, McGregor A, Geh C, Oakes S, Green C, Walker M, Newcombe N, Green S, Growcott J, Barker A, Wilkinson RW. 2009. AZD5438, a potent oral inhibitor of cyclindependent kinases 1, 2, and 9, leads to pharmacodynamic changes and potent antitumor effects in human tumor xenografts. Mol. Cancer Ther. 8:1856-1866. http://dx.doi.org/10.1158/1535-7163. MCT-08-0836.
30. Brooijmans N, Chang YW, Mobilio D, Denny RA, Humblet C. 2010. An enriched structural kinase database to enable kinome-wide structurebased analyses and drug discovery. Protein Sci. 19:763-774. http://dx.doi.org/10.1002/pro.355.
31. Chahrour O, Cairns D, Omran Z. 2012. Small molecule kinase inhibitors as anti-cancer therapeutics. Mini Rev. Med. Chem. 12:399-411. http://dx.doi.org/10. 2174/138955712800493915.
32. Bakal CJ, Davies JE. 2000. No longer an exclusive club: eukaryotic signalling domains in bacteria. Trends Cell Biol. 10:32-38. http://dx.doi.org/ 10.1016/S0962-8924 (99) 01681-5.
33. Munoz-Dorado J, Inouye S, Inouye M. 1991. A gene encoding a protein serine/threonine kinase is required for normal development of M. xanthus, a gram-negative bacterium. Cell 67:995-1006. http://dx.doi.org/10.1016/0092-8674 (91) 90372-6.
34. Hanks SK, Hunter T. 1995. Protein kinases 6. The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification. FASEB J. 9:576-596.
35. Laub MT, Goulian M. 2007. Specificity in two-component signal transduction pathways. Annu. Rev. Genet. 41:121-145. http://dx.doi.org/10.1146/ annurev. genet.41.042007.170548.
36. Lima A, Duran R, Schujman GE, Marchissio MJ, Portela MM, Obal G, Pritsch O, De Mendoza D, Cervenansky C. 2011. Serine/threonine protein kinase PrkA of the human pathogen Listeria monocytogenes: biochemical characterization and identification of interacting partners through proteomic approaches. J. Proteomics 74:1720-1734. http://dx.doi.org/10.1016/j.jprot.2011.03.005.
37. Debarbouille M, Dramsi S, Dussurget O, Nahori MA, Vaganay E, Jouvion G, Cozzone A, Msadek T, Duclos B. 2009. Characterization of a serine/threonine kinase involved in virulence of Staphylococcus aureus. J. Bacteriol. 191:4070-4081. http://dx.doi.org/10.1128/JB.01813-08.
38. Liu Q, Fan J, Niu C, Wang D, Wang J, Wang X, Villaruz AE, Li M, Otto M, Gao Q. 2011. The eukaryotic-type serine/threonine protein kinase Stk is required for biofilm formation and virulence in Staphylococcus epidermidis. PLoS One 6:e25380. http://dx.doi.org/10.1371/journal.pone.0025380.
39. Hall CL, Tschannen M, Worthey EA, Kristich CJ. 2013. IreB, a Ser/Thr kinase substrate, influences antimicrobial resistance in Enterococcus faecalis. Antimicrob. Agents Chemother. 57:6179-6186. http://dx.doi.org/10.1128/AAC.01472- 13.
40. Mir M, Asong J, Li X, Cardot J, Boons GJ, Husson RN. 2011. The extracytoplasmic domain of the Mycobacterium tuberculosis Ser/Thr kinase PknB binds specific muropeptides and is required for PknB localization. PLoS Pathog. 7:e1002182. http://dx.doi.org/10.1371/journal.ppat.1002182.
41. Shah IM, Dworkin J. 2010. Induction and regulation of a secreted peptidoglycan hydrolase by a membrane Ser/Thr kinase that detects muropeptides. Mol. Microbiol. 75:1232-1243. http://dx.doi.org/10.1111/j.1365-2958.2010.07046. x.
42. Dasgupta A, Datta P, Kundu M, Basu J. 2006. The serine/threonine kinase PknB of Mycobacterium tuberculosis phosphorylates PBPA, a penicillinbinding protein required for cell division. Microbiology 152:493-504. http://dx.doi.org/10.1099/mic.0.28630-0.